Tool for Guidance: Evidence-Based Recommendations for Managing Febrile Neutropenia

DOI QR Code

Ullmann, Andrew J. (Department of Hematology, Oncology and Pneumology, Johannes Gutenberg-University Medical Center)

Lee DG, Kim SH, Kim SY, et al. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med 2011;26:220-252. https://doi.org/10.3904/kjim.2011.26.2.220
Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:427-431. https://doi.org/10.1093/cid/ciq147
The periodic health examination. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J 1979;121:1193- 1254.
The AGREE Next Steps Consortium. The AGREE II Instrument [Internet]. The AGREE Research Trust, 2009 [cited 2011 May 15]. Available from: http://www.agreetrust.org.
Brozek JL, Akl EA, Compalati E, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 3 of 3: the GRADE approach to developing recommendations. Allergy 2011;66:588-595. https://doi.org/10.1111/j.1398-9995.2010.02530.x

ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases vol.18, pp.suppl7, 2012, https://doi.org/10.1111/1469-0691.12037